BridgeBio Pharma, Inc. Noncontrolling Interest, Decrease from Deconsolidation
BridgeBio Pharma, Inc. (BBIO) reported Noncontrolling Interest, Decrease from Deconsolidation of $179.04 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-20.
Financial Statements › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2025-02-20
- BridgeBio Pharma, Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2024-09-30 was $52.60M.
- BridgeBio Pharma, Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2024-06-30 was $126.44M.
- BridgeBio Pharma, Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2023-03-31 was $3.95M.
- BridgeBio Pharma, Inc. noncontrolling interest, decrease from deconsolidation for fiscal 2024 was $179.04M, a 4431.61% increase from fiscal 2023.
- BridgeBio Pharma, Inc. noncontrolling interest, decrease from deconsolidation for fiscal 2023 was $3.95M.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month | Noncontrolling Interest, Decrease from Deconsolidation 6 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month |
|---|---|---|---|
| 2024-12-31 | $179.04M 10-K · filed 2025-02-20 | ||
| 2024-09-30 | $52.60M 10-Q · filed 2024-11-12 | $179.04M derived: sum of 2 quarters · filed 2024-11-12 | |
| 2024-06-30 | $126.44M 10-Q · filed 2024-11-12 | ||
| 2023-12-31 | $3.95M 10-K · filed 2025-02-20 | ||
| 2023-03-31 | $3.95M 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |